Canadian Malartic Mine Initiates Construction of Underground Portal and Ramp
MONTREAL, July 30, 2020 (GLOBE NEWSWIRE) — Osisko Gold Royalties Ltd (the “Company” or “Osisko”) (OR: TSX & NYSE) is […]
AC Immune Wins Prestigious Award to Develop a “Game-Changing” Parkinson’s Diagnostic Tool
AC Immune is one of three winners sharing USD 10 million through The Michael J. Fox Foundation Ken Griffin Alpha-synuclein […]
Juniper Networks Recognized as a Leader in Open, Programmable Switches for a Businesswide Software-Defined Networking Report
SUNNYVALE, Calif., July 30, 2020 (GLOBE NEWSWIRE) — Juniper Networks (NYSE:JNPR), a leader in secure, AI-driven networks, today announced it […]
AlloVir Announces Pricing of Upsized Initial Public Offering
CAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) — AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, today announced […]
Kura Oncology to Report Second Quarter 2020 Financial Results
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the […]
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2020 Earnings and Company Updates
CAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing […]
Pacira to Report Second Quarter 2020 Financial Results on Thursday August 6, 2020
PARSIPPANY, N.J., July 30, 2020 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second […]
resTORbio Provides Corporate Update and Reports Second Quarter 2020 Financial Results
BOSTON, July 30, 2020 (GLOBE NEWSWIRE) — resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target […]
SIGA Announces Marketing Authorization Filing for oral tecovirimat with the European Medicines Agency for Multiple Indications
– Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications –NEW YORK, July 30, 2020 (GLOBE NEWSWIRE) — SIGA […]
InflaRx Reports Q2 2020 Financial & Operating Results
Announced encouraging results from the Phase II portion of the Phase II/III adaptive, randomized, controlled trial in patients with COVID-19 […]
